The molecular basis of thyroid hormone action.

Progress has been made in understanding the molecular basis of a number of clinical manifestations of thyroid disease, yet many questions remain. Why are there two thyroid hormone-receptor genes? Is the function of each of the two receptors indeed unique? How T3 receptors interact with other nuclear proteins and DNA-binding sites and how these interactions are influenced by T3 is incompletely understood. The developmental regulatory role of T3 receptor alpha 1 and its non-T3-binding alpha 2 variant needs to be defined. Most T3-regulated processes, especially those related to metabolism, muscle contraction, and brain development, function in concert with a number of other regulatory factors. The therapeutic applications of knowledge gained about the basic mechanisms of thyroid hormone action should ultimately extend beyond thyroid disease to processes regulated or influenced by T3; these include cardiac function, lipid metabolism, pituitary hormone secretion, and neural development.

[1]  S. Chernausek,et al.  Attenuation of spontaneous, nocturnal growth hormone secretion in children with hypothyroidism and its correlation with plasma insulin-like growth factor I concentrations. , 1989, The Journal of pediatrics.

[2]  F. Lönnqvist,et al.  Tissue distribution of beta 3-adrenergic receptor mRNA in man. , 1993, The Journal of clinical investigation.

[3]  N. Zuhdi,et al.  Triiodothyronine as an inotropic agent after open heart surgery. , 1989, The Journal of thoracic and cardiovascular surgery.

[4]  M. Berry,et al.  The role of selenium in thyroid hormone action. , 1992, Endocrine reviews.

[5]  M. Norman,et al.  Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells. , 1989, The Journal of clinical investigation.

[6]  P. Hallenbeck,et al.  Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter. , 1992, The Journal of biological chemistry.

[7]  J. Baxter,et al.  Hormonal regulation of expression of the endogenous and transfected human growth hormone gene. , 1987, Molecular endocrinology.

[8]  F. Ismail-Beigi Regulation of Na+,K(+)-ATPase expression by thyroid hormone. , 1992, Seminars in nephrology.

[9]  J. Oppenheimer,et al.  Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat. , 1991, The Journal of clinical investigation.

[10]  J. Burnside,et al.  Thyroid hormone regulation of thyrotropin gene expression. , 1993, Recent progress in hormone research.

[11]  N. Eberhardt,et al.  The human growth hormone gene is negatively regulated by triiodothyronine when transfected into rat pituitary tumor cells. , 1986, The Journal of biological chemistry.

[12]  S. Refetoff,et al.  Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. , 1967, The Journal of clinical endocrinology and metabolism.

[13]  R. Eaton,et al.  Myxedema-associated Cardiogenic Shock Treated with Intravenous Triiodothyronine , 1992, Annals of Internal Medicine.

[14]  I. Klein,et al.  Acute effects of triiodothyronine on arterial smooth muscle cells. , 1993, The Annals of thoracic surgery.

[15]  J. Franklyn,et al.  THYROID HORMONE RECEPTOR EXPRESSION IN THE "SICK EUTHYROID" SYNDROME , 1989, The Lancet.

[16]  M. Lazar Thyroid hormone receptors: multiple forms, multiple possibilities. , 1993, Endocrine reviews.

[17]  P. Ladenson,et al.  Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Weintraub,et al.  Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. , 1993, The New England journal of medicine.

[19]  D. Rohrer,et al.  Influence of thyroid hormone and retinoic acid on slow sarcoplasmic reticulum Ca2+ ATPase and myosin heavy chain alpha gene expression in cardiac myocytes. Delineation of cis-active DNA elements that confer responsiveness to thyroid hormone but not to retinoic acid. , 1991, The Journal of biological chemistry.

[20]  S. Rivkees,et al.  Long-term growth in juvenile acquired hypothyroidism: the failure to achieve normal adult stature. , 1987, The New England journal of medicine.

[21]  N. Wong,et al.  Advances in our understanding of thyroid hormone action at the cellular level. , 1987, Endocrine reviews.

[22]  B. Weintraub,et al.  Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone. , 1993, The Journal of clinical investigation.

[23]  M. Lazar,et al.  Dominant negative activity of an endogenous thyroid hormone receptor variant (alpha 2) is due to competition for binding sites on target genes. , 1993, The Journal of biological chemistry.

[24]  K. Woeber,et al.  Thyrotoxicosis and the heart. , 1992, The New England journal of medicine.

[25]  K. Strait,et al.  Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats. , 1990, The Journal of biological chemistry.

[26]  C. Glass,et al.  Regulation of gene expression by the thyroid hormone receptor. , 1990, Biochimica et biophysica acta.

[27]  P. Larsen,et al.  Thyroid hormone regulation of gene expression. , 1991, Annual review of physiology.

[28]  D. Darling,et al.  Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor-auxiliary protein heterodimers. , 1992, The Journal of biological chemistry.

[29]  H. Samuels,et al.  Regulation of gene expression by thyroid hormone. , 1988, The Journal of clinical investigation.

[30]  G. Childs,et al.  Triiodothyronine receptor beta-2 messenger ribonucleic acid expression by somatotropes and thyrotropes: effect of propylthiouracil-induced hypothyroidism in rats. , 1991, Endocrinology.

[31]  J. Harney,et al.  Effects of varying the position of thyroid hormone response elements within the rat growth hormone promoter: implications for positive and negative regulation by 3,5,3'-triiodothyronine. , 1991, Molecular endocrinology.

[32]  E. Morkin Regulation of Myosin Heavy Chain Genes in the Heart , 1993, Circulation.

[33]  R. Valcavi,et al.  Thyroid hormones and growth hormone secretion , 1992, Journal of endocrinological investigation.

[34]  V. Chatterjee,et al.  Thyroid hormone receptors and their role in development. , 1992, Cancer surveys.

[35]  W. Young,et al.  Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  M. Lazar,et al.  Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. , 1990, The Journal of clinical investigation.

[37]  N. Ling,et al.  Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity. , 1992, The Journal of biological chemistry.

[38]  W. Dillmann Biochemical basis of thyroid hormone action in the heart. , 1990, The American journal of medicine.

[39]  A. Samarel,et al.  Hemodynamic regulation of myosin heavy chain gene expression. Studies in the transplanted rat heart. , 1992, The Journal of clinical investigation.

[40]  L. Freedman Anatomy of the steroid receptor zinc finger region. , 1992, Endocrine reviews.

[41]  B. Hoogwerf,et al.  Long-term weight regulation in treated hyperthyroid and hypothyroid subjects. , 1984, The American journal of medicine.

[42]  J. Harney,et al.  Multihormonal regulation of the human, rat, and bovine growth hormone promoters: differential effects of 3',5'-cyclic adenosine monophosphate, thyroid hormone, and glucocorticoids. , 1988, Molecular endocrinology.

[43]  R. Weiss,et al.  The syndromes of resistance to thyroid hormone. , 1993, Endocrine reviews.

[44]  A. Root,et al.  Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. , 1991, The Journal of clinical endocrinology and metabolism.